Cart
sales@molnova.com
N4-Acetylcytidine
CAS No. 3768-18-1
N4-Acetylcytidine( —— )
Catalog No. M19336 CAS No. 3768-18-1
N4-Acetylcytidine is a modified nucleoside. N4-acetylcytidine is an endogenous urinary nucleoside product of the degradation of transfer ribonucleic acid (tRNA).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 43 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | 28 | In Stock |
|
| 500MG | 38 | In Stock |
|
| 1G | 52 | In Stock |
|
Biological Information
-
Product NameN4-Acetylcytidine
-
NoteResearch use only, not for human use.
-
Brief DescriptionN4-Acetylcytidine is a modified nucleoside. N4-acetylcytidine is an endogenous urinary nucleoside product of the degradation of transfer ribonucleic acid (tRNA).
-
DescriptionN4-Acetylcytidine is a modified nucleoside. N4-acetylcytidine is an endogenous urinary nucleoside product of the degradation of transfer ribonucleic acid (tRNA); urinary nucleosides are biological markers for patients with colorectal cancer.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number3768-18-1
-
Formula Weight285.25
-
Molecular FormulaC11H15N3O6
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 25 mg/mL (87.64 mM)
-
SMILESCC(=O)NC1=NC(=O)N(C=C1)[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Zheng YF,etal.Urinary nucleosides as biological markers for patients with colorectal cancer.World J Gastroenterol. 2005 Jul 7;11(25):3871-6.
molnova catalog
related products
-
NorA-IN-1
NorA-IN-1 is a NorA efflux inhibitor, which can be used to study overcoming multidrug resistance based on microbial efflux transporter proteins.
-
Prepro-Atrial Natriu...
Prepro-Atrial Natriuretic Factor (104-123) (human)
-
6-Hydroxyindole
6-Hydroxyindole is a reactant for asymmetrical synthesis of notoamide J as a potential biosynthetic precursor of prenylated indole alkaloids and for preparation of indoleoxyacetic acid derivatives as peroxisome proliferator-activated receptor agonists.
